BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28225338)

  • 1. Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Kamakia R; Kiazyk S; Waruk J; Meyers A; Ochanda J; Ball TB; Oyugi J
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):278-285. PubMed ID: 28225338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting.
    Clifford V; Tebruegge M; Zufferey C; Germano S; Forbes B; Cosentino L; Matchett E; McBryde E; Eisen D; Robins-Browne R; Street A; Denholm J; Curtis N
    Tuberculosis (Edinb); 2019 Jan; 114():91-102. PubMed ID: 30711163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
    Santin M; Morandeira-Rego F; Alcaide F; Rabuñal R; Anibarro L; Agüero-Balbín R; Casas-Garcia X; Pérez-Escolano E; Navarro MD; Sánchez F; Coira-Nieto A; Trigo-Daporta M; Martinez-Meñaca A; Gonzalez-Cuevas A; López-Prieto MD; Domínguez-Castellano A; Jové N;
    Clin Microbiol Infect; 2016 Dec; 22(12):1007.e1-1007.e5. PubMed ID: 27647563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.
    De Groote MA; Higgins M; Hraha T; Wall K; Wilson ML; Sterling DG; Janjic N; Reves R; Ochsner UA; Belknap R
    J Clin Microbiol; 2017 Feb; 55(2):391-402. PubMed ID: 27852671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7.
    Kim SY; Park MS; Kim YS; Kim SK; Chang J; Lee HJ; Cho SN; Kang YA
    Scand J Immunol; 2012 Dec; 76(6):580-6. PubMed ID: 22946827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cytokines for the detection of
    Nausch N; Lundtoft C; Schulz G; Henckel H; Mayatepek E; Fleischer B; Marx FM; Jacobsen M
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):270-277. PubMed ID: 28225337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
    Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
    J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.
    La Manna MP; Orlando V; Li Donni P; Sireci G; Di Carlo P; Cascio A; Dieli F; Caccamo N
    PLoS One; 2018; 13(3):e0192664. PubMed ID: 29543810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
    Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
    PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.